← Back to Dividend Calendar

FATE

FATE

Upcoming Events (1)Past Events (0)

Earnings Report

Fate Therapeutics

TBD

Report Date:

Fiscal Period:

EPS Estimate:

Rev. Estimate:

Price Target:

Oct 29, 2026

Q3 2026

-$0.27(prior yr: -$0.27)

$1.2M

$6.70